Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications. Rich ML, Khan U, Zeng C, LaHood A, et al. Int J Tuberc Lung Dis 2023;27:451-457.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rich ML, Khan U, Zeng C, LaHood A, et al. Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications. Int J Tuberc Lung Dis 2023;27:451-457.
PMID: 37231598